Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Xueer Zhao"'
Autor:
Xueer Zhao, Yueru Zhang, Oscar Trejo-Cerro, Ecem Kaplan, Zhe Li, Femke Albertsboer, Neyla El Hammiri, Filipe Colaço Mariz, Lawrence Banks, Simone Ottonello, Martin Müller
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-12 (2024)
Abstract Persistent infection with high-risk human papillomavirus (HPV) is widely recognized as the primary cause of cervical and other malignant cancers. There are six licensed prophylactic vaccines available against HPV, but none of them shows any
Externí odkaz:
https://doaj.org/article/9217cc3d10dd4b0fa85b0fbc8c538da5
Autor:
Yueru Zhang, Filipe Colaco Mariz, Peter Sehr, Gloria Spagnoli, Karl Moritz Koenig, Simay Çelikyürekli, Tim Kreuziger, Xueer Zhao, Angelo Bolchi, Simone Ottonello, Martin Müller
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-11 (2024)
Abstract The human papillomavirus minor capsid protein L2 is being extensively explored in pre-clinical studies as an attractive vaccine antigen capable of inducing broad-spectrum prophylactic antibody responses. Recently, we have developed two HPV v
Externí odkaz:
https://doaj.org/article/94f9ab3ef2084d6a85620c04ccf511de
Autor:
Filipe Colaco Mariz, Kathrin Balz, Manuela Dittrich, Yueru Zhang, Fan Yang, Xueer Zhao, Angelo Bolchi, Simone Ottonello, Martin Müller
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-15 (2022)
Abstract Skin colonization by human papillomavirus (HPV) is typically related to inconspicuous cutaneous infections without major disease or complications in immunocompetent individuals. However, in immunosuppressed patients, especially organ transpl
Externí odkaz:
https://doaj.org/article/8dd0604054e74b3ab313f8561e5ea27b
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Cervical cancer remains a global health burden despite the introduction of highly effective vaccines for the prophylaxis of causative human papillomavirus infection (HPV). Current efforts to eradicate cervical cancer focus on the development of broad
Externí odkaz:
https://doaj.org/article/6729e831007d45e5a263cc094990ff1f
Autor:
Xueer Zhao, Fan Yang, Filipe Mariz, Wolfram Osen, Angelo Bolchi, Simone Ottonello, Martin Müller
Publikováno v:
PLoS Pathogens, Vol 16, Iss 9, p e1008827 (2020)
Global burden of cervical cancer, the most common cause of mortality caused by human papillomavirus (HPV), is expected to increase during the next decade, mainly because current alternatives for HPV vaccination and cervical cancer screening programs
Externí odkaz:
https://doaj.org/article/fe95655906fe443d9d1f54ffc0cd4124
Autor:
Zhongrui Ma, Huajie Zhang, Wenjing Shang, Faliang Zhu, Weiqing Han, Xueer Zhao, Donglei Han, Peng George Wang, Min Chen
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105215 (2014)
Glycoconjugate is one of the most efficacious and safest vaccines against bacterial pathogens. Previous studies of glycoconjugates against pathogen E. coli O157:H7 focused more on the humoral responses they elicited. However, little was known about t
Externí odkaz:
https://doaj.org/article/5ed0c2d69b5c43eeadd2129913d2b530
Autor:
Junkai dong, Lan Jin, Peng George Wang, Mengyang Xue, Jie Shen, Yafei Zhai, Wanyi Guan, Yang Zou, Jun Liu, Min Chen, Wenjun Wang, Xueer Zhao
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:3764-3768
Nucleotide sugars are activated forms of monosaccharides and key intermediates of carbohydrate metabolism in all organisms. The availability of structurally diverse nucleotide sugars is particularly important for the characterization of glycosyltrans
Publikováno v:
European journal of medicinal chemistry. 80
Globotriose is involved in numerous pathogenic processes and drug development strategies. Recent studies have demonstrated that globotriosylceramide could be used in colon cancer therapy and as a crucial indicator for susceptibility to HIV-1 infectio
Autor:
Huajie Zhang, Wenjing Shang, Peng George Wang, Donglei Han, Min Chen, Xueer Zhao, Zhongrui Ma, Weiqing Han, Faliang Zhu
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 8, p e105215 (2014)
PLoS ONE, Vol 9, Iss 8, p e105215 (2014)
Glycoconjugate is one of the most efficacious and safest vaccines against bacterial pathogens. Previous studies of glycoconjugates against pathogen E. coli O157:H7 focused more on the humoral responses they elicited. However, little was known about t